New Urine Test Detects 92% of Bladder Cancer Cases

The GALEAS Bladder molecular urine test identified 92.2% of bladder cancers in a study of 964 patients across seven NHS urology departments.

The test detected all 17 muscle-invasive cancers and 35 of 36 high-grade cancers, potentially reducing the need for invasive cystoscopy procedures by 730 per 1,000 patients.

Researchers published the findings in European Urology Oncology, noting that a negative result from the test carries a 99.3% likelihood of the patient not having bladder cancer.